Thermo Fisher Scientific updated its annual profit forecast on Wednesday, raising the lower end of its earnings projection for the third time this year. The company is betting on stronger demand for its tools and services in drug development. Known for its laboratory equipment and supplies, as well as its testing services for the pharmaceutical industry, Thermo Fisher reported second-quarter profits that exceeded expectations, though revenue remained unchanged from the previous year. Fitch says the company’s strong FCF generation and
